HomeProcyrion Inc.

Procyrion Inc.

Aortix Percutaneous Mechanical Circulatory Support Device: First-in-Human Cases in Cardiorenal Syndrome Reported

Aortix percutaneous mechanical circulatory support (pMCS) device in patients with cardiorenal syndrome (CRS) have been reported. Procyrion began its pilot trial in Australia and recently expanded to the U.S. after receiving Investigational Device Exemption (IDE) approval in April...